Immunology med Skyrizi charted sales growth of 30.9% over 2026's first quarter, bringing in $4.48 billion as AbbVie's top earner.
Immunology med Skyrizi charted sales growth of 30.9% over 2026's first quarter, bringing in $4.48 billion as AbbVie's top earner.
Hosted by Jane Pauley. Featured: The effects of overtourism; horse therapy; a tool to help keep dementia in check; Sting on "The Last Ship"; a golf …
Contestants today can score the same amount - or more - with one question.
While AI makes VC faster, it’s not necessarily wiser. In healthcare, where breakthroughs rarely resemble anything the market has seen before, that distinction is everything. The …
تُعيد مجموعة من الأبحاث النظر في دور الغدة الزعترية من كونها مجرد عضو ثانوي إلى مُنظِّم قوي للشيخوخة وصحة المناعة طوال العمر